+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Aptamers Market by Product (Nucleotide Based, Peptide Based), Application (Diagnostics, Research & Development, Therapeutics Development), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904654
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Aptamers Market size was estimated at USD 1.34 billion in 2023, USD 1.48 billion in 2024, and is expected to grow at a CAGR of 10.91% to reach USD 2.77 billion by 2030.

Aptamers are single-stranded oligonucleotides, including DNA, RNA, or modified nucleic acids, that have the ability to bind specifically and with high affinity to their target molecules. These target molecules can be proteins, peptides, small organic compounds, nucleic acids, or whole cells. The importance of aptamers lies in their numerous applications in biotechnology due to their unique characteristics. They exhibit high specificity and affinity for their targets akin to antibodies and possess advantages such as smaller size, ease of chemical synthesis, and modification for stability, making them suitable candidates for targeted drug delivery systems or diagnostic tools. Moreover, aptamers have minimal immunogenicity compared to antibodies since they comprise natural nucleotides. Aptamers can be engineered for multiplex detection or combined with other biofunctional moieties, such as nanoparticles or fluorophores, to enhance their applicability across various sectors. The aptamers market is experiencing significant growth driven by various factors, such as investments in drug development, government initiatives promoting personalized medicine, and the rising development of aptamer-based biosensors and point-of-care diagnostics. However, challenges such as development complexity and regulatory limitations pose hurdles for the aptamers market. Market players are working on new production technologies to ease the aptamer manufacturing process and improve their quality. Advances in synthetic chemistry and high-throughput screening technologies have enabled the development of modified nucleic acid libraries to generate more stable and functional aptamers.

Regional Insights

The Americas region exhibits significant advancements in the global aptamer market, with an established biotechnology sector bolstered by a strong academic foundation and substantial investment in R&D activities. In terms of application areas within the Americas region, aptamers are widely used in drug discovery efforts targeting cancer therapy, treatment of inflammatory diseases, diagnosis & management. Significant advancements have been made in employing aptamers for environmental monitoring and food safety applications. Europe represents an evolving landscape for aptamers as countries such as Germany, France, and the UK have advanced biopharmaceutical sectors that use this technology extensively for therapeutic applications or diagnostics tool development. European researchers have made significant strides in using aptamers for agricultural applications, wherein they are employed to detect plant pathogens or monitor food contamination. In Asia, the aptamer landscape is at a nascent stage with potential for rapid growth due to increasing biopharmaceutical investments and government funding initiatives. Emerging markets, including China, India, South Korea, and Japan, are leading regional research activities. Although there is a limited number of dedicated aptamer-based companies in Asia compared to the Americas and Europe, these countries harbor several large-scale pharmaceutical entities that engage in aptamer research as part of their drug discovery pipelines. Asian researchers have demonstrated a growing interest in utilizing aptamers as diagnostic tools or therapeutic agents for chronic disease management, such as cardiovascular ailments or neurodegenerative conditions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Aptamers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Aptamers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Aptamers Market, highlighting leading vendors and their innovative profiles. These include 2bind GmbH, Agilent Technologies, Inc., Aptagen, LLC, Aptamer Group, Aptamer Sciences, Inc., AptaTargets SL, Aptus Biotech S.L., ATDBio Ltd., Base Pair Biotechnologies, Inc., Basking Biosciences, Cage Bio, Inc., Creative Biogene, Drive Therapeutics, LLC, IVERIC bio, Inc., Kaneka Corporation, Maravai LifeSciences, Mediomics, LLC, NeoVentures Biotechnology, Inc., NOVAPTECH, Novartis AG, Qualigen, Inc., Raptamer Discovery Group, SomaLogic, Inc., TAGCyx Biotechnologies Inc., and Vivonics, Inc.

Market Segmentation & Coverage

This research report categorizes the Aptamers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Nucleotide Based
      • DNA
      • RNA
      • XNA
    • Peptide Based
  • Application
    • Diagnostics
    • Research & Development
    • Therapeutics Development
  • End-User
    • Academic & Government Research Institutes
    • Biotechnology & Pharmaceutical Companies
    • Contract Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Aptamers Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Aptamers Market?
  3. What are the technology trends and regulatory frameworks in the Aptamers Market?
  4. What is the market share of the leading vendors in the Aptamers Market?
  5. Which modes and strategic moves are suitable for entering the Aptamers Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Aptamers Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Investments in drug development and use of aptamers for drug-binding affinity
5.1.1.2. Government initiatives encouraging personalized medicine and treatment
5.1.1.3. Rising development of aptamer-based biosensors and point-of-care diagnostics
5.1.2. Restraints
5.1.2.1. Concerns associated with short half-life of aptamers
5.1.3. Opportunities
5.1.3.1. Technological advancements in aptamer production and functionalities
5.1.3.2. Emergence use of aptamers for food safety and authenticity testing
5.1.4. Challenges
5.1.4.1. Development complexity and regulatory limitations
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Aptamers Market, by Product
6.1. Introduction
6.2. Nucleotide Based
6.3.1. DNA
6.3.2. RNA
6.3.3. XNA
6.3. Peptide Based
7. Aptamers Market, by Application
7.1. Introduction
7.2. Diagnostics
7.3. Research & Development
7.4. Therapeutics Development
8. Aptamers Market, by End-User
8.1. Introduction
8.2. Academic & Government Research Institutes
8.3. Biotechnology & Pharmaceutical Companies
8.4. Contract Research Organizations
9. Americas Aptamers Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Aptamers Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Aptamers Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. Zentek and McMaster Announce Positive Results for the Aptamer Platform
12.3.1.2. Aptamer Group and Neuro-Bio Collaborate to Develop Alzheimer’s Disease Diagnostic Test
12.3.2. New Product Launch & Enhancement
12.3.2.1. Launch of Optimer-Fc as a New Reagent Solution for Immunohistochemistry
12.3.3. Award, Recognition, & Expansion
12.3.3.1. Aptamer Opens New Facilities to Meet Growing Demand for Optimer Technology
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 2bind GmbH
13.1.2. Agilent Technologies, Inc.
13.1.3. Aptagen, LLC
13.1.4. Aptamer Group
13.1.5. Aptamer Sciences, Inc.
13.1.6. AptaTargets SL
13.1.7. Aptus Biotech S.L.
13.1.8. ATDBio Ltd.
13.1.9. Base Pair Biotechnologies, Inc.
13.1.10. Basking Biosciences
13.1.11. Cage Bio, Inc.
13.1.12. Creative Biogene
13.1.13. Drive Therapeutics, LLC
13.1.14. IVERIC bio, Inc.
13.1.15. Kaneka Corporation
13.1.16. Maravai LifeSciences
13.1.17. Mediomics, LLC
13.1.18. NeoVentures Biotechnology, Inc.
13.1.19. NOVAPTECH
13.1.20. Novartis AG
13.1.21. Qualigen, Inc.
13.1.22. Raptamer Discovery Group
13.1.23. SomaLogic, Inc.
13.1.24. TAGCyx Biotechnologies Inc.
13.1.25. Vivonics, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. APTAMERS MARKET RESEARCH PROCESS
FIGURE 2. APTAMERS MARKET SIZE, 2023 VS 2030
FIGURE 3. APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. APTAMERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. APTAMERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. APTAMERS MARKET DYNAMICS
FIGURE 7. APTAMERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. APTAMERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. APTAMERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. APTAMERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. APTAMERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. APTAMERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. APTAMERS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. APTAMERS MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 2bind GmbH
  • Agilent Technologies, Inc.
  • Aptagen, LLC
  • Aptamer Group
  • Aptamer Sciences, Inc.
  • AptaTargets SL
  • Aptus Biotech S.L.
  • ATDBio Ltd.
  • Base Pair Biotechnologies, Inc.
  • Basking Biosciences
  • Cage Bio, Inc.
  • Creative Biogene
  • Drive Therapeutics, LLC
  • IVERIC bio, Inc.
  • Kaneka Corporation
  • Maravai LifeSciences
  • Mediomics, LLC
  • NeoVentures Biotechnology, Inc.
  • NOVAPTECH
  • Novartis AG
  • Qualigen, Inc.
  • Raptamer Discovery Group
  • SomaLogic, Inc.
  • TAGCyx Biotechnologies Inc.
  • Vivonics, Inc.

Methodology

Loading
LOADING...

Table Information